The Journey To Commercialization for a Novel Medical Device Startup: Q&A with Sonavex CEO, David Narrow May 7, 2019 In the past year Sonavex has landed not one, but two FDA 510(k) clearances for their ultrasound-based medical devices. This first
Q&A with Virginia (Ginny) Espina, PhD, MT(ASCP) Dr. Ginny Espina is a Research Associate Professor at George Mason University’s Center for Applied Proteomics and Molecular Medicine. She will be the Workshop Director for the upcoming Bio-TracⓇ Symposium, “Laser Microdissection: From
Rock Creek Property Group Breaks Ground on BIO at 700 QO October 30, 2019 Rock
Global Healthcare Giant Johnson & Johnson Tapped for Next Phase of DC’s Redevelopment Plans Biotech,
Photo Credit: Dr. Alexander Sulakvelidze (LinkedIn) Intralytix Opens New HQ in Columbia, Maryland for Phage
NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer GAITHERSBURG, Md., Jan. 09, 2020 (Excerpts below were
NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team GAITHERSBURG, Md., Jan. 09, 2020 (originally published on GLOBE NEWSWIRE)
